Skip to content

HTM Securities at other companies

Eastern Bankshares, Inc. logo
Eastern Bankshares, Inc.EBC
$712.56M+61.6%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$10M
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$588.75M+354%
Associated Banc-Corp logo
Associated Banc-CorpASB
$3.57B-3.6%
Ameris Bancorp logo
Ameris BancorpABCB
$202.55M+16.6%
TPG Inc. logo
TPG Inc.TPG
$85.69M+4.0%

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.51B+96.7%

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's htm securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's HTM securities?
Ligand Pharmaceuticals (LGND) reported HTM securities of $588.75M in Q1 2026.
How has Ligand Pharmaceuticals's HTM securities changed year-over-year?
Ligand Pharmaceuticals's HTM securities increased by 354.1% year-over-year, from $129.65M to $588.75M.
What does HTM securities mean?
Debt securities the company intends and is able to hold until maturity, carried at amortized cost rather than fair value.